Additionally, preclinical studies support our results, suggesting that it is a PD-1 inhibitor rather than a CTLA-4 inhibitor that rapidly induced diabetes in adult mice (Ansari et al., 2003). Here, CTLA4 is linked to diabetes mellitus.